dr. riess on ros1 fusions in lung cancer
Published 7 years ago • 578 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:12
dr riess on treatment developments in alk and ros1 nsclc
-
1:55
multiple therapies show responses in lung cancer with ros1 fusions
-
0:56
dr. riess on the long-term benefit with immunotherapy for lung cancer
-
1:27
targeted therapies show activity in ros1 fusion-positive lung cancer
-
3:55
treatment considerations in alk/ros-1–rearranged nsclc
-
37:34
managing ros1 fusion-positive nsclc in europe and the usa | panel discussion
-
4:55
ros1-rearranged nsclc
-
1:53
ros-1 rearrangements: what are they?
-
1:53
investigating ros1 and trk rearrangements in lung cancer
-
2:58
scientific research ros 1 fusion (english)
-
4:49
emerging alk/ros1 tkis for nsclc
-
4:43
upfront therapy for alk/ros1-rearranged nsclc
-
1:45
dr. feliciano on ros1-targeted therapy in nsclc
-
59:48
patient need for novel therapies in ros1 fusion-positive non-small cell lung cancer
-
3:15
ros1 rearrangements in mnsclc
-
2:45
crizotinib treatment in lung adenocarcinoma patient with ros1 fusion – video abstract id 136297
-
4:25
overview of rare driver alterations in nsclc
-
18:41
extreme rare mutations in lung cancer (ros1, trk, her2): treatment opportunities
-
2:39
dr lin on the efficacy and safety of taletrectinib in ros1 fusion nsclc